Chromosomal microarray analysis—a routine clinical genetic test for patients with schizophrenia

This publication has 15 references indexed in Scilit:

• Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome
  American Journal of Psychiatry, 2014
• Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays
  Human Molecular Genetics, 2013
• 1q21.1 Microduplication expression in adults
  Genetics in Medicine, 2013
• A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders
  Journal of Medical Genetics, 2012
• Genetic investigation for adults with intellectual disability
  Current Opinion in Neurology, 2012
• Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia
  Schizophrenia Research, 2012
• De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia
  Molecular Psychiatry, 2011
• Genome Arrays for the Detection of Copy Number Variations in Idiopathic Mental Retardation, Idiopathic Generalized Epilepsy and Neuropsychiatric Disorders: Lessons for Diagnostic Workflow and Research
  Cytogenetic and Genome Research, 2011
• Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome
  The Journal of Pediatrics, 2011
• Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies
  The American Journal of Human Genetics, 2010